Jeffrey H. Murray

Array ( [id] => 10192933 [patent_doc_number] => 09221829 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-29 [patent_title] => 'Synthesis of triazolopyrimidine compounds' [patent_app_type] => utility [patent_app_number] => 14/344960 [patent_app_country] => US [patent_app_date] => 2012-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12772 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8955975 [patent_doc_number] => 08501748 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-06 [patent_title] => 'Method for the production of β-ketonitriles' [patent_app_type] => utility [patent_app_number] => 13/616883 [patent_app_country] => US [patent_app_date] => 2012-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16445 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13616883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10864160 [patent_doc_number] => 08889860 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-18 [patent_title] => '3′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing' [patent_app_type] => utility [patent_app_number] => 13/615284 [patent_app_country] => US [patent_app_date] => 2012-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 54490 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13615284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8567236 [patent_doc_number] => 20120329807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'Multimeric VLA-4 Antagonists Comprising Polymers Moieties' [patent_app_type] => utility [patent_app_number] => 13/606783 [patent_app_country] => US [patent_app_date] => 2012-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41414 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13606783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9831934 [patent_doc_number] => 08940750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-27 [patent_title] => 'Inhibitors of bruton\'s tyrosine kinase' [patent_app_type] => utility [patent_app_number] => 13/606949 [patent_app_country] => US [patent_app_date] => 2012-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 59393 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13606949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9254701 [patent_doc_number] => 08618117 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Amino-heterocyclic compounds' [patent_app_type] => utility [patent_app_number] => 13/600522 [patent_app_country] => US [patent_app_date] => 2012-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41152 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13600522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10831402 [patent_doc_number] => 08859569 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-14 [patent_title] => 'Substituted annellated pyrimidines and use thereof' [patent_app_type] => utility [patent_app_number] => 13/599975 [patent_app_country] => US [patent_app_date] => 2012-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66006 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13599975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9756754 [patent_doc_number] => 20140287454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'SUSCEPTIBILITY TO SELECTIVE CDK9 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/240315 [patent_app_country] => US [patent_app_date] => 2012-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 37315 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14240315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9311867 [patent_doc_number] => 08653085 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-18 [patent_title] => 'Diketopiperazine salts for drug delivery and related methods' [patent_app_type] => utility [patent_app_number] => 13/592142 [patent_app_country] => US [patent_app_date] => 2012-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 18 [patent_no_of_words] => 10783 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13592142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10499590 [patent_doc_number] => 09227984 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-05 [patent_title] => 'Therapeutically active fused pyrimidine derivatives' [patent_app_type] => utility [patent_app_number] => 14/239406 [patent_app_country] => US [patent_app_date] => 2012-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36474 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14239406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8503125 [patent_doc_number] => 20120302533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'DERIVATIVES OF PYRIMIDO [6,1-A] ISOQUINOLIN-4-ONE' [patent_app_type] => utility [patent_app_number] => 13/568754 [patent_app_country] => US [patent_app_date] => 2012-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13530 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13568754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9295357 [patent_doc_number] => 20140038991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'Protein Kinase Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/567144 [patent_app_country] => US [patent_app_date] => 2012-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11921 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13567144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9786354 [patent_doc_number] => 20140303174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-09 [patent_title] => 'Pyridazine derivatives as EAAT2 Activators' [patent_app_type] => utility [patent_app_number] => 14/236041 [patent_app_country] => US [patent_app_date] => 2012-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15562 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14236041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10325704 [patent_doc_number] => 20150210709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-30 [patent_title] => '4-OXO-3,5,7,8-TETRAHYDRO-4H-PYRANO[4,3-D]PYRMINIDINYL COMPOUNDS FOR USE AS TANKYRASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/154170 [patent_app_country] => US [patent_app_date] => 2012-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16406 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14154170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8477848 [patent_doc_number] => 20120277255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'INHIBITORS OF BRUTON\'S TYROSINE KINASE' [patent_app_type] => utility [patent_app_number] => 13/543394 [patent_app_country] => US [patent_app_date] => 2012-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 59262 [patent_no_of_claims] => 100 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13543394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8496681 [patent_doc_number] => 20120296089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'INHIBITORS OF BRUTON\'S TYROSINE KINASE' [patent_app_type] => utility [patent_app_number] => 13/543399 [patent_app_country] => US [patent_app_date] => 2012-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 59263 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13543399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10039211 [patent_doc_number] => 09079908 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-14 [patent_title] => 'Inhibitors of Bruton\'S tyrosine kinase' [patent_app_type] => utility [patent_app_number] => 13/543065 [patent_app_country] => US [patent_app_date] => 2012-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 59349 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13543065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8477847 [patent_doc_number] => 20120277254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'INHIBITORS OF BRUTON\'S TYROSINE KINASE' [patent_app_type] => utility [patent_app_number] => 13/542440 [patent_app_country] => US [patent_app_date] => 2012-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 42767 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13542440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9059979 [patent_doc_number] => 08546414 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Ion channel modulators and methods of use' [patent_app_type] => utility [patent_app_number] => 13/538667 [patent_app_country] => US [patent_app_date] => 2012-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42116 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13538667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9496587 [patent_doc_number] => 08735402 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-27 [patent_title] => 'Cycloalkyloxycarboxylic acid derivatives' [patent_app_type] => utility [patent_app_number] => 13/532305 [patent_app_country] => US [patent_app_date] => 2012-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21061 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13532305 [rel_patent_id] =>[rel_patent_doc_number] =>)